Search results
PROMOTED
Join leading experts, Prof Marianna Fontana (University College London, London, UK), Dr Esther González López (Hospital Puerta de Hierro Majadahonda, Madrid, ES), Dr Margot Davis (University of British Columbia, Vancouver, CA) and Dr Francesco Cappelli (Careggi University Hospital, Florence, IT) for a live webinar on gauging treatment success in transthyretin amyloid cardiomyopathy (ATTR-CM).This…
View more
Defining Therapeutic Success in ATTR-CM
Start date:
Jul 07, 2026
Broadcast
PROMOTED
Stay up to date with the latest clinical evidence in transthyretin amyloid cardiomyopathy (ATTR-CM) with this video series spotlighting key cardiomyopathy updates presented at ESC Heart Failure Congress (HFA) 2026.In the first session, Dr Mathew Maurer (Columbia University, New York, US) takes a deep dive into the CARDIO-TTRansform data, exploring the current treatment landscape and ongoing unmet…
View more
Spotlight on HFA 2026: Updates on Cardiomyopathies
Added:
2 months ago
Video Series
Added:
1 year ago
Predicting Right Ventricular Failure after LVAD Implantation
Added:
8 months ago
Original Research
Added:
1 year ago
HRS 2025 - Contemporary outcomes from implantable devices in non-ischemic cardiomyopathy patients observed more advanced heart failure symptoms in women at the time of ICD implantation, and white women implanted with CRT-D devices had significantly lower ventricular arrhythmia events compared to men of all races and black women implanted with both device types.Dr Valentina Kutyifa (University of…
View more
Added:
8 months ago
Device Therapies in Heart Failure
Added:
9 months ago
Review Article
Predictors of Haemolysis with Percutaneous Ventricular Assist Devices
Added:
1 year ago
Original Research
Added:
8 months ago
AHA Scientific Sessions 2025 - Dr Sarah Cuddy (Brigham and Women's Hospital, US) joins us to discuss the role of non-disease modifying treatments including SGLT2 inhibitors, mineralocorticoid receptor antagonists, GLP-1 receptor agonists, and implantable hemodynamic monitors in cardiac amyloidosis, and what this means for managing heart failure in this unique patient population.Interview…
View more
Added:
5 months ago
In this episode of Arrhythmia Academy's Journal Club, Dr David Duncker (Hannover Heart Rhythm Center, DE) is joined by Dr Marat Fudim (Duke University, US) to examine the critical early-risk period following heart failure diagnosis and the emerging role of wearable cardioverter defibrillators in sudden cardiac death prevention.The discussion centres on findings from the SCD-PROTECT study, a 19…
View more